Evidence map›Paper›PMID 41007412›Full record

ReviewBiology2025

The Role of AI-Driven De Novo Protein Design in the Exploration of the Protein Functional Universe.

Guohao Zhang, Chuanyang Liu, Jiajie Lu, Shaowei Zhang, Lingyun Zhu

Abstract readReview
In one paragraph

Review in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guohao ZhangCollege of Science, National University of Defense Technology, Changsha 410073, China.
Chuanyang LiuCollege of Science, National University of Defense Technology, Changsha 410073, China.ORCID 0000-0001-6077-3169
Jiajie LuCollege of Science, National University of Defense Technology, Changsha 410073, China.
Shaowei ZhangCollege of Science, National University of Defense Technology, Changsha 410073, China.
Lingyun ZhuCollege of Science, National University of Defense Technology, Changsha 410073, China.

Funding

National Natural Science Foundation of China No.32401056National University of Defense Technology 2023-lxy-fhjj-005National University of Defense Technology 22-TDRCJH-02-015National University of Defense Technology 24-ZZCX-JDZ-02
6 · The paper itself

Abstract

The extraordinary diversity of protein sequences and structures gives rise to a vast protein functional universe with extensive biotechnological potential. Nevertheless, this universe remains largely unexplored, constrained by the limitations of natural evolution and conventional protein engineering. Substantial evidence further indicates that the known natural fold space is approaching saturation, with novel folds rarely emerging. AI-driven de novo protein design is overcoming these constraints by enabling the computational creation of proteins with customized folds and functions. This review systematically surveys the rapidly advancing field of AI-based de novo protein design, reviewing current methodologies and examining how cutting-edge computational frameworks accelerate discovery through three complementary vectors: (1) exploring novel folds and topologies; (2) designing functional sites de novo; (3) exploring sequence-structure-function landscapes. We highlight key applications across therapeutic, catalytic, and synthetic biology and discuss the persistent challenges. By fusing recent progress and the existing limitations, this review outlines how AI is not only accelerating the exploration of the protein functional universe but also fundamentally expanding the possibilities within protein engineering, paving the way for bespoke biomolecules with tailored functionalities.

Indexed as

AI-driven toolkitde novo protein designprotein functional universe

Identifiers

PMID41007412
PMCPMC12467925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.